Counterpart to Registration Rights Agreement August 11, 2014

EX-10.204 10 ex10204-rracounterpartre53.htm AUG RRA-5375-2023 Ex. 10.204 - RRA Counterpart re 5 375% Notes due 2023 (DAVA Guarantee)
Exhibit 10.204

EXECUTION VERSION

Counterpart to Registration Rights Agreement
August 11, 2014
The undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated June 30, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, Citigroup Global Markets Inc. and RBC Capital Markets, relating to the 5.375% Senior Notes due 2023, to be bound by the terms and provisions of such Registration Rights Agreement.




Exhibit 10.204

IN WITNESS WHEREOF, the undersigned has executed this counterpart as of the date first written above.
DAVA PHARMACEUTICALS, INC.
By:
/s/ Deanna Voss
Name:
Deanna Voss
Title:
Assistant Secretary


[Signature to Registration Rights Agreement Counterpart - 5.375% Senior Notes due 2023]